In a recent research, LINC00941 was shown to enhance pancreatic cancer growth by competing with miR-335-5p to inhibit the ROCK1-mediated LIMK1/cofilin-1 signaling pathway [22]. Here, CFL1 is linked to familial pancreatic carcinoma.